Anesthesia Management of Retroperitoneal Adrenalectomies

NCT ID: NCT00894335

Last Updated: 2011-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a prospective, perioperative evaluation of hemodynamic and respiratory parameters in patients undergoing retroperitoneoscopic adrenalectomies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Due to their underlying disease, patients with adrenal tumors are prone to episodes of hyper- and hypotension. Furthermore, excessive hypercarbia and an increased arterial-alveolar CO2 difference can be seen during these operations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adrenal Tumors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Pheochromocytoma

No interventions assigned to this group

2

Conn-Syndrome

No interventions assigned to this group

3

Cushing disease

No interventions assigned to this group

4

Metastasis

No interventions assigned to this group

5

Non-functional tumor

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with an adrenal tumor

Exclusion Criteria

* Age below 18 years
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kliniken Essen-Mitte

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Anesthesiology and CCM , Clinics Essen-Mitte

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Harald Groeben, Prof, M.D.

Role: PRINCIPAL_INVESTIGATOR

Clinics Essen-Mitte

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinics Essen-Mitte

Essen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Harald Groeben, Prof., M.D.

Role: CONTACT

##49 201 174 ext. 31109

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Harald Groeben, Prof, M.D.

Role: primary

##49 201 174 ext. 31109

Harald Groeben, Prof, M.D.

Role: backup

##49 201 174 ext. 31109

References

Explore related publications, articles, or registry entries linked to this study.

Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, Ommer A, Groeben H, Peitgen K, Janssen OE, Philipp T, Neumann HP, Schmid KW, Mann K. Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery. 2006 Dec;140(6):943-8; discussion 948-50. doi: 10.1016/j.surg.2006.07.039.

Reference Type BACKGROUND
PMID: 17188142 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

retroper adrenal

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.